Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2019-08-02
|
| gptkbp:ATCCode |
L01EX14
|
| gptkbp:CASNumber |
1029044-16-3
|
| gptkbp:chemicalFormula |
C22H15F2N5O2
|
| gptkbp:contraindication |
pregnancy
severe hepatic impairment |
| gptkbp:drugClass |
gptkb:receptor_tyrosine_kinase
|
| gptkbp:genericName |
gptkb:pexidartinib
|
| gptkbp:hasBoxedWarning |
hepatotoxicity
|
| https://www.w3.org/2000/01/rdf-schema#label |
Turalio
|
| gptkbp:indication |
tenosynovial giant cell tumor
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Daiichi_Sankyo
|
| gptkbp:mechanismOfAction |
CSF1R inhibitor
|
| gptkbp:pregnancyCategory |
D
|
| gptkbp:prescriptionRequired |
https://www.turalio.com/
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea fatigue liver toxicity swelling dysgeusia hair color changes increased ALT increased AST |
| gptkbp:bfsParent |
gptkb:Servier_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|